San Francisco, Ca., USA - April 2, 2014, San Francisco, Ca., USA - Medivation, Inc. a biopharmaceutical company, announced the appointment of Rick Bierly as chief financial officer.
Article continues below
Mr. Bierly will serve as Medivation's principal financial and accounting officer. Mr. Bierly brings to Medivation more than 30 years' experience in finance roles at Glaxo-SmithKline, Aventis, Centocor and Johnson & Johnson. Among these roles were biotechnology CFO, diagnostics CFO, Treasurer, External Reporting director, head of shared services and operational finance roles in support of sales, marketing, supply chain and R&D.
He began his career in public accounting at Ernst & Young (EY), and most recently served as an executive director in EY's Financial Accounting Advisory Services practice. Mr. Bierly holds a Bachelor of Business Administration degree from Pennsylvania State University and is a CPA in PA and NJ.
After more than 10 years as Medivation's chief business and financial officer, Patrick Machado is retiring from his position.
Mr. Machado served as an Interim Chief Business and Financial Officer at Medivation, Inc. since November 2013. Mr. Machado served as the Chief Financial Officer of Medivation, Inc. from December 17, 2004 to November 2013 and served as its Chief Business Officer from December 2009 to November 2013. Mr. Machado served as the Principal Accounting Officer of Medivation, Inc. He served as Senior Vice President of Medivation, Inc. since December 17, 2004 and also served as its Secretary until April 2013.
He served as Senior Vice President, Chief Financial Officer of Medivation, Inc. since September 2003. From 1998 to 2001, Mr. Machado served at Product Health, Inc. where he served as its Vice President, Chief Financial Officer and General Counsel from 1998 to 2000 and as Senior Vice President and Chief Financial Officer from 2000 to 2001. From 2001 to 2002, he served as a consultant to Cytyc Corporation to assist with transitional matters related to Cytyc Corporations acquisition of Product Health, Inc. ■